Company: BSX
Filing Date: 2025-03-19
Form Type: DEF 14A
Source: 0000885725-25-000017
Chunk: 119

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-03-19
Form: DEF 14A
Chunk 119
---
 |   |       |     |    |     | Number of SecuritiesRemaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in Column (a)) (c) |            |     |    |
|:--------------------------------------------------------------|:----|:-----------------------------------------------------------------------------------------------|-----------:|:----|:---------------------------------------------------------------|:----|:--|------:|:----|---:|:----|:-----------------------------------------------------------------------------------------------------------------------------------------------|-----------:|:----|---:|
| Equity compensation plans approved by security holders(1)     |     |                                                                                                | 28,663,788 |     |                                                                |     | $ | 40.80 |     | -2 |     |                                                                                                                                                | 52,384,437 |     | -3 |
| Equity compensation plans not approved by security holders(4) |     |                                                                                                |          — |     |                                                                |     |   |     — |     |    |     |                                                                                                                                                |          — |     |    |
| Total                                                         |     |                                                                                                | 28,663,788 |     |                                                                |     | $ | 40.80 |     |    |     |                                                                                                                                                | 52,384,437 |     |    |

(1) Amounts in columns (a) and (b) include outstanding options under our 2011 LTIP. T he amount in column (a) also includes 9,480,318 shares awarded under our 2011 LTIP in the form of service‐based RSUs, Company performance‐based RSUs and restricted stock. Of such amount, approximately 2,024,313 shares are issuable upon settlement of outstanding Company performance‐based RSUs. Shares underlying the 2022, 2023 and 2024 rTSR performance‐based RSUs are earned over a three‐year performance and service period. The 2022 rTSR performance‐based RSUs have been included based on actual performance. The 2023 rTSR and 2024 rTSR performance‐based RSUs have been included assuming maximum achievement of the Company performance criteria and achievement of the individual service criteria of the program (200% of the target units awarded). We have included the number of shares underlying the maximum number of units in column (a) for both the 2023 rTSR and 2024 rTSR because the Company’s rTSR performance during the two‐year period from January 1, 2023 through December